![Allan Wehnert](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Allan Wehnert
No más puestos en curso
Health Technology
Perfil
Allan Wehnert is the founder of Orocidin AS, established in 2023, and holds the title of Chief Executive Officer.
Former jobs include VP-R&D Project Strategy & Portfolio Management at H.
Lundbeck A and Senior Vice President-Clinical, R&D Strategy at Initiator Pharma A.
Cargos activos de Allan Wehnert
| Empresas | Cargo | Inicio |
|---|
Antiguos cargos conocidos de Allan Wehnert.
| Empresas | Cargo | Fin |
|---|---|---|
| INITIATOR PHARMA A/S | Director Técnico/Científico/I+D | - |
| H. LUNDBECK A/S | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Initiator Pharma A/S
 Initiator Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs to unmet medical needs within the central & peripheral nervous system | Health Technology |
- Bolsa de valores
- Insiders
- Allan Wehnert
